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Abstract: Intravascular ultrasound (IVUS) provides valuable anatomic information about the 
coronary arterial lumen, wall, and plaques that cannot be assessed by coronary angiography 
alone. For over 2 decades, IVUS has been shown to be a helpful tool for identifying significant 
ischemia in angiographically intermediate left main (LM) or non-LM lesions by measuring 
the minimum luminal area. It can also guide percutaneous coronary intervention (PCI) in 
complex coronary lesions such as LM, bifurcation, chronic total occlusion, in-stent restenosis, 
and long or calcified lesions. In these complex lesions, IVUS can reduce stent thrombosis or 
restenosis by accurate lesion assessment and detection of stent underexpansion, malapposition, 
or edge dissections. Through further intervention based on these IVUS findings, optimal stent 
deployment can be achieved. IVUS can also identify the culprit lesion with plaque rupture, and 
vulnerable lesions with a large plaque burden or thin-cap fibroatheroma. Although other new 
imaging modalities with improved resolution and technologies are attracting increased clinical 
attention, IVUS remains the most reliable intracoronary imaging modality to guide PCI until 
other new imaging devices are proven to be useful and improve clinical outcomes. However, 
current data on clinical utility are conflicting and the guidelines do not recommend routine use 
of IVUS when performing angiography or PCI. In this review, we focus on issues related to the 
selection of patients who might benefit from IVUS guidance and discuss future perspectives 
on intracoronary imaging.
Keywords: intravascular ultrasound, angiography, coronary artery disease
Introduction
Coronary angiography is still the gold standard for the diagnosis of coronary artery 
disease. However, two-dimensional angiography has inherent limitations such as 
vessel overlap or possible foreshortening, which can cause a misdiagnosis of disease 
severity.1
Intravascular ultrasound (IVUS) is a catheter-based imaging modality that  provides 
cross-sectional images of the coronary artery, enabling measurement of luminal and 
vessel areas.2 When it was first developed in the 1970s, the initial role of IVUS was to 
evaluate plaques in atherosclerotic coronary arteries.3 With the development of automatic 
lesion analysis software and enhanced imaging of metallic stent struts, the applica-
tion of IVUS was further extended to guide successful coronary stent implantation.3 
 Currently, IVUS can accurately identify plaque burden,  morphology, and characteristics. 
As IVUS quantification of coronary stenosis has fewer  anatomic limitations than 
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angiography, it can be especially useful when angiographic 
diameter stenosis is considered indeterminate or unreliable.4 
However, the most important role of IVUS in current clinical 
practice might be as an adjunct when performing percutaneous 
coronary intervention (PCI). IVUS is a very useful tool for 
lesion assessment before PCI in complex cases such as left 
main (LM) stenosis,  calcified lesions, or  bifurcations.5 IVUS 
is also helpful during PCI to evaluate stent sizing, expansion, 
apposition, and edge dissection.3 After PCI, it can be used 
to determine the cause of stent failure, including in-stent 
restenosis and stent thrombosis (ST).6
Most experts agree that IVUS guidance improves the quality 
and outcomes of PCI. In many studies, IVUS-guided PCI has 
been shown to be associated with lower rates of adverse clinical 
events compared with angiography-guided PCI.7–10 However, 
there are also controversial data  regarding the benefit of IVUS 
guidance with respect to  clinical outcomes.11–15 Clinical studies 
evaluating the  utility of IVUS are described in Table 1. There 
are two possible explanations for why angiography-guided 
PCI achieves similar clinical outcomes to IVUS-guided PCI. 
First, IVUS has significantly increased our understanding 
of the mechanisms of stent failure and poor outcomes. As a 
result, most operators usually perform sufficient lesion prepa-
ration and postdilation to minimize stent underexpansion or 
 malapposition. These procedures are now possible without 
IVUS guidance. Second, the improved performance of newer 
generation drug-eluting stents (DESs) may have reduced the 
impact of IVUS guidance on clinical outcomes.
In this context, both American and European guidelines 
similarly acknowledge the benefit of IVUS in selected cases 
only, such as LM or stent failure lesions.16,17 These current 
guidelines do not recommend routine IVUS for lesion 
Table 1 Studies comparing outcomes between iVUS-guided and angiography-guided PCi
Study Design N (IVUS vs  
angiography)
Inclusion Follow-up,  
months
Outcome measure Results (IVUS vs 
angiography)
P-value
Kim et al11 RCT 269 vs 274 Long lesions  
(stents $28 mm)
12 Composite of 
cardiovascular  
death, ST, Mi, TVR
4.5% vs 7.3% 
4.0% vs 8.1%*
NS 
P=0.048*
Jakabcin et al12 RCT 105 vs 105 Complex cases 18 Composite of  
death, Mi, TVR
11% vs 12% NS
Chieffo et al15 RCT 142 vs 142 Complex lesions 24 Composite of cardiac  
death, Mi, TVR
16.9% vs 23.2% NS
witzenbichler  
et al7
Observational 3,349 vs 5,234 All comers 12 Definite/probable  
ST, Mi 
Composite of  
cardiac death, ST, Mi
0.6% vs 1.0% 
2.5% vs 3.7% 
3.1% vs 4.7%
P=0.02 
P=0.002 
P,0.001
Roy et al10 Observational 884 vs 884  
by matching
All comers 12 Definite ST 0.7% vs 2.0% P=0.014
Park et al13 Observational 463 vs 463  
by matching
Nearly all comers 12 Composite of cardiac  
death, Mi, TLR
4.3% vs 2.4% P=0.047
Youn et al14 Observational 125 vs 216 Primary PCi cases 36 Composite of  
death, Mi, TLR, TVR
12.8% vs 18.1% NS
Kim et al37 Observational 487 vs 487  
by matching
Non-left main  
bifurcation lesions
36 Death or Mi 3.8% vs 7.8% P=0.03
Hong et al40 Observational 201 vs 201  
by matching
Chronic total  
occlusion lesions
24 Definite/probable  
ST, Mi
0% vs 3.0% 
1.0% vs 4.0%
P=0.014 
P=0.058
Jang et al8 Meta-analysis 11,793 vs  
13,056
3 RCT 12  
observational  
studies
Not  
applicable
Death 
Definite/probable ST 
Mi 
TVR
OR 0.64; 95% Ci 0.51–0.81 
OR 0.59; 95% Ci 0.42–0.82 
OR 0.57; 95% Ci 0.42–0.78 
OR 0.81; 95% Ci 0.68–0.95
P,0.001 
P=0.002 
P,0.001 
P=0.01
Ahn et al9 Meta-analysis 12,499 vs  
14,004
3 RCT 14  
observational  
studies
Not  
applicable
Death 
Definite/probable ST 
Mi 
TVR
OR 0.61; 95% Ci 0.48–0.79 
OR 0.59; 95% Ci 0.47–0.75 
OR 0.57; 95% Ci 0.44–0.75 
OR 0.81; 95% Ci 0.66–1.00
P,0.001 
P,0.001 
P,0.001 
P=0.046
de la Torre 
Hernandez  
et al35
Meta-analysis 505 vs 505  
by matching
4 observational  
studies on left  
main lesions
36 Composite of cardiac 
death, Mi, TLR 
Definite/probable ST
11.3% vs 16.4% 
0.6% vs 2.2%
P=0.04 
P=0.04
Note: *Result from per-protocol analysis.
Abbreviations: iVUS, intravascular ultrasound; PCi, percutaneous coronary intervention; RCT, randomized control trial; ST, stent thrombosis; Mi, myocardial infarction; 
TVR, target vessel revascularization; NS, not significant; TLR, target lesion revascularization; OR, odds ratio; CI, confidence interval.
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Table 2 Studies correlating IVUS with FFR to identify functionally significant lesions
Lesion subset Study N Angiographic DS% FFR IVUS parameters Reliability
Left main lesions Jasti et al20 55 Not defined ,0.75 MLA ,5.9 mm2 
MLD ,2.8 mm
Sensitivity 93%, specificity 95% 
Sensitivity 93%, specificity 98%
Kang et al23 55 30–80 ,0.75 
,0.80
MLA ,4.1 mm2 
MLA ,4.8 mm2
Sensitivity 95%, specificity 83% 
Sensitivity 89%, specificity 83%
Park et al22 112 30–80 #0.80 MLA #4.5 mm2 Sensitivity 77%, specificity 82%
Non-left main lesions Lee et al27 94 30–75 ,0.75 MLA #2.0 mm2 Sensitivity 82%, specificity 81%
Kang et al25 201 30–75 ,0.80 MLA ,2.4 mm2 Sensitivity 90%, specificity 60%
waksman et al28 350 40–80 ,0.80 MLA ,3.07 mm2 Sensitivity 64%, specificity 65%
Briguori et al26 53 40–70 ,0.75 MLA #4.0 mm2 Sensitivity 92%, specificity 56%
Abbreviations: IVUS, intravascular ultrasound; FFR, fractional flow reserve; DS, diameter stenosis; MLA, minimum luminal area; MLD, minimum luminal diameter.
assessment when revascularization is not being  contemplated. 
Therefore, judicious selection of patients who can  benefit 
from IVUS-guided PCI is very important in clinical  practice. 
Although several reviews have addressed the roles or advan-
tages of IVUS, few of them specifically address the appropriate 
patient groups for IVUS evaluation. In this review, we focus 
on the issues related to patient selection for IVUS-guided PCI 
and the future perspectives of intracoronary imaging.
Angiographically intermediate 
lesions
Fractional flow reserve (FFR) is the gold standard for the assess-
ment of functional significance in angiographically intermediate 
lesions.18 Although positive predictive values of IVUS measure-
ments were not satisfactory for the identification of ischemia, 
there have been many attempts to  correlate IVUS measurements 
with the functional significance of stenotic lesions.19
Left main lesions
IVUS measurements demonstrated a relatively strong correla-
tion with FFR when evaluating intermediate LM lesions. The 
limited variability of LM coronary artery length, diameter, 
and the amount of supplied myocardium explains the better 
correlation for LM lesions compared to non-LM lesions.4 The 
most widely used parameter is the minimum luminal area 
(MLA). Jasti et al showed that MLA ,5.9 mm2 and minimum 
luminal diameter ,2.8 mm correlated well with FFR <0.75 
with a sensitivity and specificity 90% (Table 2).20 This MLA 
value was prospectively tested in the LITRO study.21 PCI was 
deferred in 96% (179/186) of patients with MLA $6.0 mm2 
and only eight (4.5%) patients in the deferred group required 
subsequent LM revascularization during a 2-year follow-up. 
None of the patients in that study suffered myocardial infarc-
tion. Thus, it is safe to defer PCI for intermediate LM lesions 
with MLA $6.0 mm2. In the Asian population with smaller 
normal coronary diameters, an MLA cutoff #4.5 mm2 
correlates with FFR #0.8.22,23 Recently, the Society of 
 Cardiovascular Angiography and Interventions released an 
expert consensus statement regarding IVUS in LM disease. 
Experts recommend that IVUS can be used to appraise the sig-
nificance of LM stenosis, employing a cutoff MLA of 6 mm2 
to assess whether revascularization is warranted.4  Currently, 
IVUS is a class IIa recommendation in the assessment of 
angiographically indeterminant LM lesions.16,17
Non-left main lesions
One limitation of an IVUS MLA for predicting the hemo-
dynamic significance of intermediate non-LM lesions is 
that the functional effects of non-LM lesions are dependent 
on additional factors besides MLA.4 These factors include 
lesion location in the coronary tree, lesion length, eccentricity, 
entrance and exit angle, shear forces, reference vessel diam-
eters, and the amount of viable myocardium subtended by the 
lesion.24 Many investigators have tried to establish a reliable 
IVUS MLA cutoff value in intermediate non-LM lesions, by 
which operators can confidently perform ischemia-driven PCI. 
However, there is variation in the MLA cutoff values derived 
from many studies (Table 2).25–28 FIRST was a multicenter 
prospective registry study of patients who had intermediate 
non-LM stenosis (40%–80%) on angiography. Although 
an IVUS MLA ,3.07 mm2 was the best cutoff value for 
FFR ,0.8, its sensitivity and specificity were low (64% and 
65%, respectively).28 The correlation between IVUS and FFR 
values is weak in demonstrating significant lesions, and their 
correlation is best for demonstrating nonsignificant lesions.29 
When considering the combined results of many IVUS/FFR 
correlation studies, an MLA $4.0 mm2 has reasonable accu-
racy in identifying nonsignificant lesions for which PCI can 
be safely deferred.4,5 However, FFR remains the gold standard 
for confirming the functional significance of  intermediate 
non-LM lesions if MLA is ,4.0 mm2. Experts agree that 
IVUS measurements for the determination of non-LM lesion 
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severity should not be relied on for revascularization in the 
absence of additional functional evidence.4
Left main stenting
Undoubtedly, LM stenosis is the most critical subset of 
 coronary disease. Given the potential disastrous consequences 
of procedural failure resulting in ST or restenosis,  IVUS-guided 
PCI should be strongly recommended as the standard of care 
during LM PCI.30 IVUS guidance in LM PCI is a class IIa17 
or IIb16 recommendation in the current guidelines.
IVUS has been used to clarify the distribution, burden, 
and composition of plaque in LM lesions. Complete recogni-
tion of these factors is crucial for planning and performing 
LM PCI. In contrast to angiography findings, IVUS identi-
fies the diffuse nature of plaques involving not only the LM 
segment but also both flow dividers (left anterior descending 
artery, LAD and left circumflex artery, LCX).31 Continuous 
plaque from the LM segment into the proximal LAD was 
seen in 90% of cases, into the LCX in 66.4%, and into both 
LAD and LCX in 62%. Additionally, in the setting of distal/
bifurcation LM lesions, the importance of performing IVUS 
pullbacks from both LAD and LCX has been highlighted.32 
This is because of the inaccuracy of assessing lumen dimen-
sions of the LCX ostium by IVUS pullback from LAD. IVUS 
is also critical for the optimization of post-procedural MLA 
to reduce the restenosis rate. A previous IVUS study showed 
that post-stenting MLA cutoff values that best predicted in-
stent restenosis on a segment basis were 5.0 mm2 in ostial 
LCX, 6.3 mm2 in ostial LAD, 7.2 mm2 in polygon of con-
fluence (confluence zone of LAD and LCX), and 8.2 mm2 
in LM. Post-stenting underexpansion was an independent 
predictor for major adverse cardiac events.33
There are few appropriately designed studies examining 
whether IVUS-guided PCI is better than angiography-guided 
PCI in LM lesions. However, in a post-hoc analysis from the 
MAIN-COMPARE (revascularization for unprotected LM 
coronary artery stenosis: comparison of percutaneous coro-
nary angioplasty vs surgical revascularization) registry, the 
IVUS-guided PCI group showed a lower 3-year cumulative 
mortality rate than the angiography-guided PCI group for 
LM lesions (4.7% vs 16%, P=0.048). Of note, these favorable 
outcomes were seen exclusively in patients who were treated 
with DES.34 It has been postulated that the benefit of IVUS 
guidance was associated with a reduced incidence of sudden 
cardiac death caused by late ST. A recently published study 
on DES in LM lesions also showed a lower 3-year  composite 
rate of cardiac death, myocardial infarction, and target lesion 
revascularization (TLR) in the IVUS-guided PCI group 
compared with the angiography-guided PCI group (11.3% vs 
16.4%, P=0.04). These trends were more prominent in the 
subgroup with distal LM lesions (10% vs 19.3%, P=0.03).35 
Therefore, the necessity for meticulous IVUS evaluation in 
LM PCI is once again emphasized, especially in distal LM 
lesions. Figure 1 shows a representative case of IVUS-guided 
LM intervention.
Bifurcation lesions
Coronary bifurcation PCI represents 10%–15% of PCI 
 procedures.36 Although many devices and techniques have 
been introduced, coronary bifurcation lesions are still a chal-
lenging field of interventional cardiology because of the lower 
procedural success rate and unfavorable clinical outcomes 
compared with non-bifurcation lesions.37 Furthermore, it is 
difficult to decide on an adequate stent technique and whether 
to intervene in compromised side branches, both of which 
depend on many factors including bifurcation anatomy and 
plaque distribution.38 Bifurcation lesions may show dynamic 
changes during PCI, with plaque/carina shift or dissection 
leading to side branch compromise and requiring adjustment 
to the interventional approach.36 Therefore, accurate anatomic 
characterization of bifurcation lesions may improve stent 
sizing and deployment techniques. After stent deployment, 
IVUS can detect edge dissection, stent underexpansion, or 
stent malapposition, which have been strongly associated 
with future stent failure. Kim et al showed that the 3-year 
cumulative incidence of death or myocardial infarction was 
significantly lower in the IVUS-guided PCI group compared 
to the angiography-guided PCI group for bifurcation lesions 
(3.8% vs 7.8%, P=0.03).37 Two-stent technique and final kiss-
ing balloon were more frequently used in the IVUS-guided 
PCI group. However, most of the patients with bifurcation 
lesions do not require a two-stent technique and most of the 
angiographically significant side branches are functionally 
insignificant.38,39 Therefore, unnecessary intervention to side 
branches might be avoided by meticulous IVUS evaluation, 
even in true bifurcation lesions. In another study regarding 
complex bifurcation lesions (nearly 90% of the lesions were 
medina class 1, 1, 1), the number of implanted stents was 
significantly lower in the IVUS-guided PCI group.36 Also, 
the rate of TLR was significantly lower in the IVUS-guided 
PCI group (6% vs 21%, P=0.001). In this regard, the role of 
IVUS in decreasing the TLR rate may become more impor-
tant in patients with the most complex bifurcation lesions. 
A decrease in the number of stents in the IVUS-guided PCI 
group may have reduced the TLR rate. Also in that study, 
stent underexpansion was found in 27% of patients in the 
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IVUS-guided PCI group, and these findings prompted further 
intervention.36 Given the high incidence of stent underex-
pansion leading to further intervention and lower rates of 
TLR or ST in the IVUS group, these findings suggest that 
IVUS might prevent adverse clinical outcomes specifically 
in patients in whom stent underexpansion is discovered.36 
Also, avoidance of unnecessary post-dilation to compromise 
side branches as well as adequate stent expansion without 
compromising side branches might be the important advan-
tages of using IVUS.37 In these contexts, liberal and active 
use of IVUS in bifurcation PCI is encouraged. Figure 2 
shows a representative case of IVUS-guided intervention 
for bifurcation lesion.
Chronic total occlusions
Successful PCI of chronic total occlusion (CTO) has been 
associated with an improvement of angina, left ventricular 
function, and survival, compared with failed PCI of CTO.40,41 
However, an increased risk of ST after CTO  recanalization 
with DES has been suggested because of delayed re-
endothelialization, exposure of deep plaque components, 
persistence of well-developed collaterals, long stenting, and 
high incidence of stent malapposition.40 Also, CTO lesions 
show a higher restenosis rate than other lesion subsets, even 
with DES.42 Pre-PCI IVUS can accurately measure the 
 reference vessel diameter and lesion length for appropriate 
stent sizing when it is difficult for operators to accurately 
decide stent size with angiography alone, especially in CTO 
lesions. Post-PCI IVUS may detect PCI complications or 
suboptimal stent deployment such as stent edge dissection, 
underexpansion, malapposition, or incomplete lesion cover-
age, which subsequently necessitate further intervention.40 
Thus, IVUS could lead to optimal stent deployment with 
improved clinical outcomes. Hong et al showed that IVUS-
guided PCI reduced the 2-year cumulative incidence of 
ST compared with angiography-guided PCI (0% vs 3.0%, 
P=0.014).40 Furthermore, in subgroup analysis of TLR, a 
significant interaction was observed between the use of 
IVUS and lesion length for predicting TLR (P=0.037), sug-
gesting the usefulness of IVUS in long-lesion ($30 mm) 
relative to short-lesion (,30 mm) CTO. In a recent CTO 
study, in-stent late luminal loss at 1-year follow-up was 
A B
f 7.9 mm2
c 10.0 mm2
d 6.6 mm2
e 10.4 mm2 g 15.7 mm2 h 8.2 mm2
b 1.1 mm2a 7.8 mm2
Figure 1 A 54-year-old male presenting with unstable angina showed significant stenosis of left main coronary artery (LMCA).
Notes: The patient had undergone percutaneous coronary intervention at the LMCA to proximal left anterior descending artery with a sirolimus-eluting stent. (A) Pre-intervention: 
cross-sectional intravascular ultrasound images from a (proximal) to d (distal) showed attenuated plaque and significant luminal stenosis of LMCA (minimal lumen area: 1.11 mm2). 
(B) Post-intervention: cross-sectional images from e (proximal) to h (distal) showed that the minimal lumen area increased to 7.9 mm2 after intervention. Arrows in (A) and (B) 
indicate the sequence of intravascular ultrasound images.
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 significantly lower in the  IVUS-guided group compared with 
the  angiography-guided group (0.28±0.48 vs 0.46±0.68 mm, 
P=0.025), although these angiographic findings were not 
translated into improved clinical outcomes.43 With the 
enhanced performance of the next-generation DES, clinical 
outcomes can be more importantly attributed to procedural 
factors. Thus, optimization of stent implantation with IVUS 
guidance could be important for the next-generation DES.40 
Another advantage of IVUS in CTO lesions might be its 
ability to assist in antegrade or retrograde recanalization of 
the CTO segment. CTO recanalization with a guide wire is 
the most important and difficult step in CTO intervention. 
IVUS can give information about the exact location of the 
guide wire (ie, true lumen vs subintima) and help find the 
entry point of the occlusion. Even when the guide wire enters 
into the subintimal space, IVUS may facilitate the discovery 
of the true lumen.3 Moreover, IVUS has been successfully 
used during more complex retrograde approaches in which 
the lesion is approached from both directions and a balloon 
is advanced over the antegrade wire and inflated within 
the subintimal space, permitting the IVUS catheter to be 
advanced and positioned subintimally. Under IVUS guid-
ance, the retrograde wire can then be manipulated from the 
subintimal space into the true lumen and beyond the occluded 
segment.3 It should be noted that a lot of experience is needed 
to correctly interpret IVUS images.44,45 In general, however, 
IVUS-guided PCI is recommended in CTO lesions.
Long lesions
A long lesion itself inevitably increases the stent length, and 
long stent increases the incidence of stent malapposition or 
underexpansion. Stent malapposition or underexpansion is 
A
B
Bf
12.6 mm2
d 15.2 mm2
e 2.8. mm2
j 14.2 mm2h 5.9 mm2 i 9.3 mm2g
f
9.5 mm2
c 2.9 mm2a 9.0 mm2 b 3.6 mm2
Figure 2 A 62-year-old male presenting with unstable angina showed significant stenosis of distal left main coronary artery (LMCA) bifurcation.
Notes: The patient had undergone percutaneous coronary intervention at LMCA to proximal left anterior descending (LAD) artery and proximal left circumflex artery (LCX) 
with a crushing stent technique. (A) Pre-intervention: cross-sectional intravascular ultrasound images from a (proximal) to e (distal) showed significant luminal stenosis of distal 
LMCA bifurcation lesions (minimal lumen area 3.6 mm2 in LMCA, 2.9 mm2 in proximal LAD, and 2.8 mm2 in proximal LCX). (B) Post-intervention: cross-sectional images from 
f (proximal) to j (distal) showed that the minimal lumen area increased to 9.5 mm2 in LMCA, 9.3 mm2 in proximal LAD, and 5.9 mm2 in proximal LCX.
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a well-known risk factor for future stent failure. Therefore, 
performing PCI for long lesions can be problematic, and the 
rate of ST may be higher in this lesion subset.11,46 IVUS can 
provide useful information about the status of a long stent 
that can lead to stent optimization and overcome the potential 
deleterious effect of long lesions. Therefore, IVUS-guided 
PCI in long lesions is expected to decrease the incidence of 
adverse clinical events. In a multicenter randomized study 
involving 543 patients treated with stent length $28 mm, 
IVUS guidance did not improve the clinical outcomes (1-year 
composite rate of cardiovascular death, myocardial infarc-
tion, target vessel revascularization, and ST) compared to 
angiographic guidance (4.5% vs 7.3%, P=0.16 in intention 
to treat analysis).11 However, when per protocol analysis 
was applied, the benefits of IVUS were significant (4.0% vs 
8.1%, P=0.048). This discrepancy may be explained by the 
insufficient sample size and considerable crossover rate. 
Therefore, a larger scale prospective study (impact of IVUS 
guidance on long-term clinical outcomes of  everolimus-eluting 
stents in long coronary lesions) is currently underway to 
establish the effect of the IVUS guidance in long-lesion 
PCI.
Calcified lesions
Clinical factors associated with calcified lesions include 
increased patient age, male sex, hypertension, diabetes, 
stable (vs unstable) angina, and renal function, especially 
the need for hemodialysis.47 Calcium is assessed quantita-
tively with IVUS according to the arc and length. Calcium 
is described qualitatively according to its location: lesion vs 
reference and superficial vs deep (leading edge of the acous-
tic shadow within the deepest 50% of the plaque and media 
thickness). There is general agreement that the greater the 
arc, length, or thickness of calcium on IVUS, the greater the 
l ikelihood of stent underexpansion and malapposition that 
can be associated with adverse events, including restenosis 
and ST.35,48,49 In the setting of severe calcification, iterative 
IVUS imaging in conjunction with repeated high-pressure 
balloon inflations can be used to optimize stent expansion and 
apposition.  Furthermore, lesion preparation with a  cutting/
scoring balloon or rotational atherectomy can be used to 
optimize stent implantation in a way not possible using 
angiography alone.47
In-stent restenosis
In-stent restenosis remains one of the main problems after 
metallic stent implantation. The process of restenosis is 
complex, and there are many factors that can influence the 
neointimal proliferation process within the stented segment: 
procedure-related factors such as stent underexpansion or 
traumatic injury of vessel wall at stent edges; stent-related 
mechanical factors such as stent fractures or damaged poly-
mers; and biological factors such as drug resistance.3 In PCI 
for in-stent restenosis, IVUS can assist in the differentiation 
of restenosis that is related predominantly to intimal hyper-
plasia vs mechanical complications, such as stent fracture or 
 underexpansion.5 IVUS-guided high-pressure angioplasty with 
a noncompliant balloon is often performed when stent under-
expansion is the major mechanism for restenosis to avoid the 
deployment of a second stent. Balloon-alone angioplasty may 
also be appropriate in the presence of very focal lesions caused 
by neointimal hyperplasia. In patients with diffuse or prolif-
erative in-stent restenosis, a second DES is often warranted.5 
The use of IVUS to guide PCI in patients with restenosis is 
a class IIa recommendation in the current PCI guidelines.16,17 
Figure 3 shows a representative case of IVUS-guided interven-
tion in stented lesions with significant stenosis.
Future perspectives
Optical coherence tomography
Although IVUS is the most widely used intracoronary imag-
ing modality in interventional cardiology, it is used in fewer 
than 20% of PCI procedures.6 As intracoronary imaging is 
increasingly focusing on plaque/neointima characteriza-
tion and neointimal coverage of the stent, the relatively low 
resolution of IVUS (100–150 µm) becomes a weakness. 
 Intracoronary optical coherence tomography (OCT) has 
emerged as an attractive new imaging modality with superior 
resolution (10–15 µm).50 It offers a clear view around the 
vessel lumen or stent edges and in vivo plaque/neointima 
 evaluation.6 However, OCT cannot consistently visualize 
external elastic membrane because of its shallow penetration 
depth (1–2 mm), and thus cannot measure vessel size or plaque 
burden with confidence. Several studies have also reported 
that lumen dimensions measured by OCT were smaller than 
those measured by IVUS.50–52 In a previous study comparing 
IVUS and OCT measurements (listed in Table 3), the lumen 
areas measured by OCT were much smaller than those mea-
sured by IVUS (mean difference, 1.11–1.67 mm2).53 These 
differences in measurements between OCT and IVUS may 
decrease the size or deployment pressure of the stent and 
adjuvant balloon in  OCT-guided PCI, which could lead to stent 
 underexpansion.54 The paradigm of IVUS guidance for stent 
optimization that has developed over the past 2 decades does 
not translate directly to OCT.6 Moreover, although OCT has 
much higher resolution and adds more information, it is not 
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Table 3 Comparison between iVUS and OCT measurements
Study N Study protocol IVUS measurements OCT measurements P-value
Yamaguchi et al50 76 iVUS vs OCT measurements  
in the same native vessel
MLD 2.3±0.6 mm 
MLA 5.6±2.6 mm2
MLD 2.2±0.7 mm 
MLA 5.2±2.8 mm2
P=0.008 
P,0.001
Okamura et al51 19 iVUS vs OCT measurements  
in the same native vessel
Minimum stent area 
6.26±2.01 mm2
Minimum stent area 
5.84±1.89 mm2
Not significant
Bezerra et al52 100 iVUS vs OCT measurements  
in the same native vessel
MLA 3.32±1.92 mm2 MLA 2.33±1.56 mm2 P,0.001
IVUS-guided PCI OCT-guided PCI
Habara et al54 70 iVUS-guided PCi vs  
OCT-guided PCi
Minimum stent area 7.1±2.1 mm2 
Mean stent area 8.7±2.4 mm2
Minimum stent area 6.1±2.2 mm2 
Mean stent area 7.5±2.5 mm2
P=0.04 
P=0.04
Abbreviations: iVUS, intravascular ultrasound; OCT, optical coherence tomography; MLD, minimum luminal diameter; MLA, minimum luminal area; PCi, percutaneous 
coronary intervention.
A
B
a 9.4 mm2 b 2.8 mm2 c 10.1 mm2 d 5.3 mm2
e 8.9 mm2 f 5.6 mm2 g 11.5 mm2 h 6.3 mm2
Figure 3 A 60-year-old patient presenting with acute myocardial infarction had a history of drug-eluting stent (sirolimus-eluting stent 3.5 × 33 mm) implantation in the 
proximal left anterior descending (LAD) artery 6 years previously.
Notes: Emergency coronary angiography revealed significant narrowing in the previously stented segment at proximal LAD, suggestive of very late stent thrombosis. (A) 
Pre-intervention: cross-sectional intravascular ultrasound images from a (proximal) to d (distal) showed neointimal hyperplasia with aneurysm formation (white arrow in c). 
(B) Post-intervention coronary angiogram of the previously stented segment: cross-sectional images from e (proximal) to h (distal) after stent implantation.
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clear whether this additional information improves clinical 
outcomes. Because OCT, like IVUS, evaluates anatomic 
dimensions rather than functional significance, its use in 
assessing lesion physiology will be limited.4 Nevertheless, 
with its enhanced resolution it is expected that OCT will be 
a useful imaging tool to guide PCI.
Culprit lesion and vulnerable plaque
In patients with acute coronary syndrome, plaque rupture 
occurs in 60%–65% of cases, plaque erosion in 30%–35%, 
and a calcified nodule in 5%.48 The final common pathway 
is thrombus formation. Although the culprit lesion is some-
times evident, some patients have either no identifiable 
culprit lesion, or multiple potential culprit lesions. IVUS 
detects plaque rupture in approximately one-half of ST-
segment elevation myocardial infarction culprit lesions.55,56 
However, the superior resolution and obligatory flushing with 
OCT can sharply outline the vascular lumen area, and thus 
optimize identification of ruptured plaques.48
The precursor of the ruptured thrombotic plaque is the 
thin-cap fibroatheroma, the most common type of vulner-
able plaque. To date, only virtual-histology (VH)-IVUS has 
been shown to predict future events.48 VH-IVUS is based 
on spectral analysis of radiofrequency data acquired with 
IVUS catheters and uses these results to identify four dif-
ferent tissue types: fibrous tissue, fibrofatty tissue, necrotic 
core, and dense calcium.3 In the PROSPECT study, predic-
tors of non-culprit future events at 3 years were a thin-cap 
fibroatheroma on VH-IVUS, IVUS MLA ,4.0 mm2, and 
IVUS plaque burden 70%.57 Although VH-IVUS can 
only infer the presence of the thin-cap fibroatheroma by the 
presence of a necrotic core abutting the lumen, OCT is able 
to identify many features, including fibrous cap thickness, 
macrophages in the fibrous cap, and an underlying lipid 
core.48 The appropriateness of routine invasive imaging to 
screen for vulnerable plaques and stenting of these vulnerable 
plaques is a current subject of debate.
Future direction of intracoronary imaging
The introduction of IVUS has significantly increased our 
knowledge and the understanding of balloon angioplasty, 
stent implantation, and stent failure. IVUS has been estab-
lished as the most validated and reliable intracoronary 
imaging modality to guide PCI in angiographic intermedi-
ate lesions and complex lesions. Until other intracoronary 
imaging techniques such as OCT can validate lumen mea-
surements for optimal stent deployment and demonstrate 
improvement in clinical outcomes, IVUS will remain the first 
choice to guide PCI.6 High-frequency IVUS catheters that 
are under investigation may provide better resolution than the 
current version of IVUS.58 Other imaging modalities, such 
as near-infrared spectroscopy, have also been developed to 
detect lipid composition. In addition, forward-looking IVUS 
systems are under investigation, and may assist in CTO 
intervention.5,59 However, the future of intravascular imaging 
may be the integration of functional and anatomical assess-
ment (ie, a combined IVUS and FFR catheter).19 Currently 
available imaging modalities have their own advantages and 
disadvantages, and thus, they are complementary rather than 
competitive with one another. Therefore, a combined catheter 
that integrates two or more modalities and allows real-time 
coregistration of images acquired from different transducers 
will certainly attract clinical attention.3 Dual-modality imag-
ing probes combining IVUS and OCT have been shown to 
be feasible in several studies.60 A combined near-infrared 
spectroscopy and IVUS catheter has been developed and 
introduced for clinical use.61 Combined information obtained 
from these catheters would be very helpful for enhancing 
PCI quality, and ultimately improving clinical outcomes. 
Besides this technological progress, patients are becoming 
older, and the diabetic problem is getting larger worldwide, 
both of which will result in more complex coronary lesions 
and increased PCI. Intracoronary imaging has been proven 
to be a useful asset in complex coronary intervention, and 
will remain so for many years to come in the predicted future 
patient population.3
Conclusion
IVUS provides valuable anatomic information about the 
coronary vessel lumen, wall, and plaque. However, IVUS 
should be used cautiously for physiologic assessment of 
angiographic intermediate lesions. IVUS and FFR are 
complementary techniques that can guide decision-making 
for these lesions. In complex coronary lesions, IVUS is 
useful for accurate lesion assessment, stent optimization, 
and detection of complications. Therefore, it can reduce the 
rate of stent failure and improve clinical outcomes in such 
lesions. IVUS can also help to identify culprit lesions and 
vulnerable plaques. Newer imaging modalities with higher 
resolution (such as OCT) are increasingly being used to guide 
coronary intervention. However, these new devices need to 
be validated and show an acceptable improvement in clinical 
outcomes. Until then, IVUS will remain the most validated 
tool, and the first choice for guiding PCI.
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